According to Goldstein Research, global cancer services market is expected to grow at a CAGR of 15.0% over the forecast period 2016-2024.Growing awareness among the people about preventive measures available for cancer is driving the growth of cancer services market all across the globe. Global cancer services market segmentation has been carried out on the basis of preventive care services, diagnostic care services, applications and end-user. Based on preventive care services vaccines are the dominating segment owing to its positive results in cancer treatment. Vaccines for cancer services market is expected to occupy over 62% market share over the forecast period. Global cancer services market is dominated by North America that holds 45% revenue share of global cancer services market in 2016 followed by Europe and is expected to dominate during the forecast period. Asia-Pacific region is fastest growing market due to increasing frequency of breast, stomach and lungs cancer.
Market Segmentation
On the basis of our in-depth analysis, Global Cancer Services Market can be segmented as follows:
• Based On Preventive Care Services
o By Vaccines
o By Cancer Growth Inhibitors

• Based On Diagnostic Care Services
o By Diagnostic Tests
o By Biopsy
o By Endoscopy
o By Imaging
o By Cancer Therapies

• Based On Application
o Blood Cancer
o Breast Cancer
o Colorectal Cancer
o Kidney Cancer
o Lungs Cancer
o Other Application (Skin Cancer, Gastrointestinal Tract Cancer, Liver Cancer)

• Based On End-User
o Cancer Hospitals
o Diagnostic Centers
o Special Clinics

• By Region
o North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
o Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
o Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}


“Global Cancer Services Market Outlook 2024”contains detailed overview of the global cancer services market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by preventive care services, by diagnostic care services, by application and by end-user.
Further, for the in-depth analysis, Global Cancer Services Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such asGE Healthcare, Philips Healthcare, Siemens Healthcare, Novartis, Abbott Diagnostics, Roche, Pfizer Inc., Sanofi, Amgen, Merck & Co., GlaxoSmithKline, Johnson & Johnson, Amgen Inc., Eli Lilly and Company, Hoffman La-Roche Ltd. and Roche Holdings Ltd, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents the global cancer services market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Download Exclusive Sample Report @ https://www.goldsteinresearch.com/request-sample/cancer-services-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024
About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.
Contact for more Info:
Steve Blade
(Global Sales Head)
USA: + 1-646-568-7747
Canada: +1-437-886-1181
UK: +44-203-318-6627
[email protected]